Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia
Publikation: Beitrag in Fachzeitschrift › Forschungsartikel › Beigetragen › Begutachtung
Beitragende
- Psychosoziale Medizin und Entwicklungsneurowissenschaften
- University of Oslo
- deCODE Genetics
- Keck School of Medicine at University of Southern California
- Johnson & Johnson
- Université de Lausanne
- Vrije Universiteit Amsterdam (VU)
- Amsterdam University Medical Centers (UMC)
- National Ageing Research Institute
- University of Melbourne
- Forschungszentrum Jülich
- Heinrich Heine Universität Düsseldorf
- JARA-Brain Institute I Brain structure function relationships
- Umeå University
- Murdoch University
- University of Toronto
- University of Texas Rio Grande Valley School of Medicine
- Radboud University Nijmegen
- University of Bergen
- Haukeland University Hospital
- University of New South Wales
- Utrecht University
- Ernst-Moritz-Arndt-Universität Greifswald
- University of New Mexico
- Royal College of Surgeons in Ireland
- University of California at San Diego
- Universität Basel
- King's College London (KCL)
- Trinity College Dublin
- Hospital Universitario Marques de Valdecilla
- CIBER - Centro de Investigación Biomédica en Red
- University of Cape Town
- South London and Maudsley NHS Foundation Trust
- Queensland University of Technology
- University of California at Davis
- University of Galway
- Max-Planck-Institut für Kognitions- und Neurowissenschaften
- Massachusetts General Hospital
- Athinoula A. Martinos Center for Biomedical Imaging
- Max Planck Institute for Psycholinguistics
- Commissariat à l’énergie atomique et aux énergies alternatives (CEA)
- National Institutes of Natural Sciences - National Institute for Physiological Sciences
- Yale University
- Institute of Living
- Humboldt-Universität zu Berlin
- University of Stellenbosch
- Charité – Universitätsmedizin Berlin
Abstract
Carriers of large recurrent copy number variants (CNVs) have a higher risk of developing neurodevelopmental disorders. The 16p11.2 distal CNV predisposes carriers to e.g., autism spectrum disorder and schizophrenia. We compared subcortical brain volumes of 12 16p11.2 distal deletion and 12 duplication carriers to 6882 non-carriers from the large-scale brain Magnetic Resonance Imaging collaboration, ENIGMA-CNV. After stringent CNV calling procedures, and standardized FreeSurfer image analysis, we found negative dose-response associations with copy number on intracranial volume and on regional caudate, pallidum and putamen volumes (β = −0.71 to −1.37; P < 0.0005). In an independent sample, consistent results were obtained, with significant effects in the pallidum (β = −0.95, P = 0.0042). The two data sets combined showed significant negative dose-response for the accumbens, caudate, pallidum, putamen and ICV (P = 0.0032, 8.9 × 10−6, 1.7 × 10− 9, 3.5 × 10−12 and 1.0 × 10−4, respectively). Full scale IQ was lower in both deletion and duplication carriers compared to non-carriers. This is the first brain MRI study of the impact of the 16p11.2 distal CNV, and we demonstrate a specific effect on subcortical brain structures, suggesting a neuropathological pattern underlying the neurodevelopmental syndromes.
Details
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 584-602 |
Seitenumfang | 19 |
Fachzeitschrift | Molecular psychiatry |
Jahrgang | 25 |
Ausgabenummer | 3 |
Publikationsstatus | Veröffentlicht - 1 März 2020 |
Peer-Review-Status | Ja |
Externe IDs
PubMed | 30283035 |
---|---|
ORCID | /0000-0003-2132-4445/work/160950896 |
ORCID | /0000-0002-1753-7811/work/160953377 |